Cargando…

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients

PURPOSE: Adjuvant chemotherapy (aCT) in rectal cancer patients who have undergone curative resection after neoadjuvant chemoradiation (nCRT) is controversial. We aimed to investigate the benefits of using aCT and the clinical impact of completing aCT in ypstage 2 rectal cancer patients. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Youn Young, Lee, Kang Young, Kim, Nam Kyu, Lee, Sat Byol, Kim, Ga Ram, Min, Byung Soh, Oh, Seong-Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Coloproctology 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6968722/ https://www.ncbi.nlm.nih.gov/pubmed/31937073 http://dx.doi.org/10.3393/ac.2019.03.10

Ejemplares similares

Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer
por: Lee, Yong Joon, et al.
Publicado: (2018)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
por: You, Kai-yun, et al.
Publicado: (2014)

The impact of early adjuvant chemotherapy in rectal cancer
por: Noh, Gyoung Tae, et al.
Publicado: (2020)

Endoscopy and magnetic resonance imaging-based prediction of ypT stage in patients with rectal cancer who received chemoradiotherapy: Results from a prospective study of 110 patients
por: Cho, Min Soo, et al.
Publicado: (2019)

Oncologic effects of adjuvant chemotherapy in patients with ypT0–2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis
por: Ha, Gi Won, et al.
Publicado: (2020)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer
por: Kim, Woo Ram, et al.
Publicado: (2015)

Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
por: Oh, Soo Young, et al.
Publicado: (2021)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
por: Galata, Christian, et al.
Publicado: (2018)

The Impact of Postoperative Complications on Long-term Oncologic Outcomes After Laparoscopic Low Anterior Resection for Rectal Cancer
por: Park, Eun Jung, et al.
Publicado: (2016)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Impact of anastomotic leakage on long-term oncologic outcome and its related factors in rectal cancer
por: Noh, Gyoung Tae, et al.
Publicado: (2016)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

Is adjuvant chemotherapy necessary for patients with ypT0–2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
por: Lu, Zhao, et al.
Publicado: (2018)

Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors
por: Cheong, Chinock, et al.
Publicado: (2022)

Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers
por: Jeong, Gyu-Seong, et al.
Publicado: (2020)

Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
por: Yoon, Kyu Jong, et al.
Publicado: (2011)

Prognostic Impact of Immunonutritional Status Changes During Preoperative Chemoradiation in Patients With Rectal Cancer
por: Lee, Yong Joon, et al.
Publicado: (2016)

The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
por: Kim, Jun Won, et al.
Publicado: (2010)

Stratified Prognostic Value of Pathological Response to Preoperative Treatment in yp II/III Rectal Cancer
por: Yang, Yanpeng, et al.
Publicado: (2021)

Predicting stage ypT0–1N0 for nonradical management in patients with middle or low rectal cancer who undergo neoadjuvant chemoradiotherapy: a retrospective cohort study
por: Lee, Jeehye, et al.
Publicado: (2022)

Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer
por: Chen, Yue, et al.
Publicado: (2023)

Reply to Hsueh YP et al.
por: Nambot, Sophie, et al.
Publicado: (2020)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
por: Han, Yoon Dae, et al.
Publicado: (2015)

Robotic Low Ligation of the Inferior Mesenteric Artery for Rectal Cancer Using the Firefly Technique
por: Bae, Sung Uk, et al.
Publicado: (2015)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis
por: Kuo, Yu-Hsuan, et al.
Publicado: (2022)

Different clinical features according to the anastomotic leakage subtypes after rectal cancer surgeries: contained vs. free leakages
por: Park, Eun Jung, et al.
Publicado: (2018)

Risk Factors for Lymph Node Metastasis and Oncologic Outcomes in Small Rectal Neuroendocrine Tumors with Lymphovascular Invasion
por: Nam, Seung-Joo, et al.
Publicado: (2022)

Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series
por: Bae, Sung Uk, et al.
Publicado: (2014)

Cost-Effectiveness of Robotic Surgery for Rectal Cancer Focusing on Short-Term Outcomes: A Propensity Score-Matching Analysis
por: Kim, Chang Woo, et al.
Publicado: (2015)

Comparison of trans-anal endoscopic operation and trans-anal excision of rectal tumors
por: Al Bandar, Mahdi Hussain, et al.
Publicado: (2017)

Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports
por: Rami, Sairafi, et al.
Publicado: (2016)

Short and Long-Term Outcomes of Robotic versus Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Case-Matched Retrospective Study
por: Cho, Min Soo, et al.
Publicado: (2015)

Circumferential Resection Margin Involvement in Stage III Rectal Cancer Patients Treated with Curative Resection Followed by Chemoradiotherapy: A Surrogate Marker for Local Recurrence?
por: Kang, Jeonghyun, et al.
Publicado: (2013)

Evaluation of recombinant adenovirus-mediated gene delivery for expression of tracer genes in catecholaminergic neurons
por: Kim, Mi-La, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f07vc070l7os4jv0g7urqvl4fn